Astal Laboratories Intrinsic Value
ASTALLTD Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹118.80 | ₹95.04 - ₹142.56 | +45.5% | EPS: ₹9.90, Sector P/E: 12x |
| Book Value Method | asset | ₹36.00 | ₹32.40 - ₹39.60 | -55.9% | Book Value/Share: ₹36.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹80.80 | ₹72.72 - ₹88.88 | -1.1% | Revenue/Share: ₹101.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹90.00 | ₹81.00 - ₹99.00 | +10.2% | EBITDA: ₹15.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹158.40 | ₹142.56 - ₹174.24 | +94.0% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹85.14 | ₹76.63 - ₹93.65 | +4.3% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹160.00 | ₹144.00 - ₹176.00 | +95.9% | ROE: 27.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹72.00 | ₹64.80 - ₹79.20 | -11.8% | EPS: ₹9.90, BVPS: ₹36.00 |
Want to compare with current market value? Check ASTALLTD share price latest .
Valuation Comparison Chart
ASTALLTD Intrinsic Value Analysis
What is the intrinsic value of ASTALLTD?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Astal Laboratories (ASTALLTD) is ₹90.00 (median value). With the current market price of ₹81.66, this represents a +10.2% variance from our estimated fair value.
The valuation range spans from ₹36.00 to ₹160.00, indicating ₹36.00 - ₹160.00.
Is ASTALLTD undervalued or overvalued?
Based on our multi-method analysis, Astal Laboratories (ASTALLTD) appears to be trading below median value by approximately 10.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 46.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.75 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 27.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.60x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Astal Laboratories
Additional stock information and data for ASTALLTD
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-13 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-6 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |